Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2025-12-24 @ 5:08 PM
NCT ID:
NCT00767650
Eligibility Criteria:
* INCULSION CRITERIA:
* Diagnosed with aplastic anemia.
* Co-enrolled on a Clinical Center CsA treatment protocol that prescribes CsA (included but not limited to initial treatment cohort in both rabbit and horse ATG arm for the aplastic anemia patients).
* Age greater than or equal to 15 years old.
EXCLUSION CRITERIA:
* Prior use of cyclosporine within 6 months to next line of treatment.
* History of learning disability (i.e. dyslexia).
* Unable to read and speak English (the neuropsychological testing tools are validated for use in English speaking subjects only).
* Life expectancy less than six months or when clinical status prevents full performance with testing.
* Either adult patients or guardians for the minor patient, unable to comprehend the investigational nature of the study and provide informed consent.
* Inability or unwillingness to come to Clinical Center for the 6-month and 12-month follow-up appointments.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT00767650
Study Brief:
Protocol Section:
NCT00767650